Concepedia

J. Siekmann

JS

Statistics

Publications

6

Citations

376

H-Index

6

Active since

2000

Affiliations

Baxter (Austria)(Current)

J. Siekmann is an author at Baxter (Austria) specializing in pegylation, medicine, and pharmacology.

Publications per year

2000–2015

6

Publications

6

von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.

J A Dean, Victor S. Blanchette, Manuel Carção et al. · PubMed · 2000 · 120 citations

, , +17

BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.

Peter L. Turecek, M.J. Bossard, Michael Graninger et al. · PubMed · 2012 · 96 citations

, , +13

Safety of PEGylated recombinant human full‐length coagulation factor VIII (BAX 855) in the overall context of PEG and PEG conjugates

Reinhard Stidl, Sebastian Fuchs, M.J. Bossard et al. · Haemophilia · 2015 · 59 citations · Full text

, , +13

Development of a plasma- and albumin -free recombinant von Willebrand factor

Peter L. Turecek, Artur Mitterer, H. Peter Matthiessen et al. · Hämostaseologie · 2009 · 59 citations · Full text

, , +15

GEMMA and MALDI-TOF MS of reactive PEGs for pharmaceutical applications

Jasmin Kemptner, Martina Marchetti‐Deschmann, J. Siekmann et al. · Journal of Pharmaceutical and Biomedical Analysis · 2010 · 24 citations

, , +5

1–5 of 6